ILF2 and breast neoplasm: Furthermore, using three GEO datasets (GSE100534, GSE148283, and GSE173661), we found that ILF2 was more highly expressed specifically in BCBrM sites than in primary breast tumours, brain tumours in situ and other metastatic sites, such as the lung, liver, and kidney (Figure 6L–N).